SLC2A1 and Hyperglycemia: We identify the molecular mechanism by which intracellular S1P dynamically regulates GLUT activity and provide evidence that RBC employ it as safeguard against pathophysiological metabolic conditions such as hyperglycemia in human and murine diabetes mellitus.